Cargando…
Onco-fertility and personalized testing for potential for loss of ovarian reserve in patients undergoing chemotherapy: proposed next steps for development of genetic testing to predict changes in ovarian reserve
Women of reproductive age undergoing chemotherapy face the risk of irreversible ovarian insufficiency. Current methods of ovarian reserve testing do not accurately predict future reproductive potential for patients undergoing chemotherapy. Genetic markers that more accurately predict the reproductiv...
Autores principales: | Sun, Bei, Yeh, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244159/ https://www.ncbi.nlm.nih.gov/pubmed/34193292 http://dx.doi.org/10.1186/s40738-021-00105-7 |
Ejemplares similares
-
Ovarian reserve tests
por: Jirge, Padma Rekah
Publicado: (2011) -
An Update on Ovarian Aging and Ovarian Reserve Tests
por: Amanvermez, Ramazan, et al.
Publicado: (2016) -
Fertility With Early Reduction of Ovarian Reserve
por: Kesharwani, Dipanshu K, et al.
Publicado: (2022) -
Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide
por: Lemos, Claudia NCD, et al.
Publicado: (2010) -
Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility
por: Nguyen, Quynh-Nhu, et al.
Publicado: (2018)